279 related articles for article (PubMed ID: 29708242)
1. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation.
Desai AR; Maulvi FA; Pandya MM; Ranch KM; Vyas BA; Shah SA; Shah DO
Biomater Sci; 2018 May; 6(6):1580-1591. PubMed ID: 29708242
[TBL] [Abstract][Full Text] [Related]
2. Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis.
Maulvi FA; Singhania SS; Desai AR; Shukla MR; Tannk AS; Ranch KM; Vyas BA; Shah DO
Int J Pharm; 2018 Sep; 548(1):139-150. PubMed ID: 29960036
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
4. Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release.
Desai AR; Maulvi FA; Desai DM; Shukla MR; Ranch KM; Vyas BA; Shah SA; Sandeman S; Shah DO
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110885. PubMed ID: 32409042
[TBL] [Abstract][Full Text] [Related]
5. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
Hsu KH; Carbia BE; Plummer C; Chauhan A
Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
[TBL] [Abstract][Full Text] [Related]
6. Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: In vitro and in vivo evaluation.
Maulvi FA; Shaikh AA; Lakdawala DH; Desai AR; Pandya MM; Singhania SS; Vaidya RJ; Ranch KM; Vyas BA; Shah DO
Acta Biomater; 2017 Apr; 53():211-221. PubMed ID: 28131945
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma.
Xu J; Ge Y; Bu R; Zhang A; Feng S; Wang J; Gou J; Yin T; He H; Zhang Y; Tang X
J Control Release; 2019 Jul; 305():18-28. PubMed ID: 31103677
[TBL] [Abstract][Full Text] [Related]
8. Extended drug delivery by contact lenses for glaucoma therapy.
Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
J Control Release; 2012 Aug; 162(1):152-8. PubMed ID: 22721817
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation.
Yang H; Zhang F; Fan Y; Zhang J; Fang T; Xing D; Zhen Y; Nie Z; Liu Y; Wang D; Li J
Pharm Res; 2024 Mar; 41(3):531-546. PubMed ID: 38366235
[TBL] [Abstract][Full Text] [Related]
10. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses.
Jung HJ; Abou-Jaoude M; Carbia BE; Plummer C; Chauhan A
J Control Release; 2013 Jan; 165(1):82-9. PubMed ID: 23123188
[TBL] [Abstract][Full Text] [Related]
11. Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation.
Maulvi FA; Patil RJ; Desai AR; Shukla MR; Vaidya RJ; Ranch KM; Vyas BA; Shah SA; Shah DO
Acta Biomater; 2019 Mar; 86():350-362. PubMed ID: 30625414
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery by contact lens in spontaneously glaucomatous dogs.
Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
[TBL] [Abstract][Full Text] [Related]
13. Modification of timolol release from silicone hydrogel model contact lens materials using hyaluronic acid.
Guidi G; Korogiannaki M; Sheardown H
Eye Contact Lens; 2014 Sep; 40(5):269-76. PubMed ID: 25162288
[TBL] [Abstract][Full Text] [Related]
14. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
15. Sustained Delivery of Timolol Using Nanostructured Lipid Carriers-Laden Soft Contact Lenses.
Tian C; Zeng L; Tang L; Yu J; Ren M
AAPS PharmSciTech; 2021 Aug; 22(6):212. PubMed ID: 34378099
[TBL] [Abstract][Full Text] [Related]
16. Extended release of hyaluronic acid from hydrogel contact lenses for dry eye syndrome.
Maulvi FA; Soni TG; Shah DO
J Biomater Sci Polym Ed; 2015; 26(15):1035-50. PubMed ID: 26176811
[TBL] [Abstract][Full Text] [Related]
17. A medical device/drug delivery system for treatment of glaucoma.
Schultz CL; Poling TR; Mint JO
Clin Exp Optom; 2009 Jul; 92(4):343-8. PubMed ID: 19389129
[TBL] [Abstract][Full Text] [Related]
18. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
Jung HJ; Chauhan A
Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
Tighsazzadeh M; Mitchell JC; Boateng JS
Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of brimonidine loaded silica nanoparticles-laden silicone contact lenses to manage glaucoma.
Xu Y; Li H
J Biomater Appl; 2022 Aug; 37(2):333-343. PubMed ID: 35482359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
